Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 1:13:180.
doi: 10.3389/fnins.2019.00180. eCollection 2019.

Iron in Neurodegeneration - Cause or Consequence?

Affiliations
Review

Iron in Neurodegeneration - Cause or Consequence?

Alain Ndayisaba et al. Front Neurosci. .

Abstract

Iron dyshomeostasis can cause neuronal damage to iron-sensitive brain regions. Neurodegeneration with brain iron accumulation reflects a group of disorders caused by iron overload in the basal ganglia. High iron levels and iron related pathogenic triggers have also been implicated in sporadic neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple system atrophy (MSA). Iron-induced dyshomeostasis within vulnerable brain regions is still insufficiently understood. Here, we summarize the modes of action by which iron might act as primary or secondary disease trigger in neurodegenerative disorders. In addition, available treatment options targeting brain iron dysregulation and the use of iron as biomarker in prodromal stages are critically discussed to address the question of cause or consequence.

Keywords: autophagic-lysosomal dysfunction; iron; mitochondrial dysfunction; neurodegeneration; neurodegenerative mechanisms; neuroinflammation; protein aggregation.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Cellular and subcellular dysregulation linked with brain iron accumulation. 5′-UTR, 5′ untranslated region; ACSL-4, Acyl-CoA Synthetase Long Chain Family Member 4; GPX, gluthathione peroxidase; RNA, ribonucleic acid; ROS, reactive oxygen species.

Similar articles

Cited by

References

    1. Abdalkader M., Lampinen R., Kanninen K. M., Malm T. M., Liddell J. R. (2018). Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front. Neurosci. 12:466. 10.3389/fnins.2018.00466 - DOI - PMC - PubMed
    1. Adlard P. A., Bica L., White A. R., Nurjono M., Filiz G., Crouch P. J., et al. (2011). Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer’s disease. PLoS One 6:e17669. 10.1371/journal.pone.0017669 - DOI - PMC - PubMed
    1. Adlard P. A., Sedjahtera A., Gunawan L., Bray L., Hare D., Lear J., et al. (2014). A novel approach to rapidly prevent age-related cognitive decline. Aging Cell 13 351–359. 10.1111/acel.12178 - DOI - PMC - PubMed
    1. Agrawal S., Fox J., Thyagarajan B., Fox J. H. (2018). Brain mitochondrial iron accumulates in Huntington’s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically. Free Radic. Biol. Med. 120 317–329. 10.1016/j.freeradbiomed.2018.04.002 - DOI - PMC - PubMed
    1. Ahmadi S., Ebralidze I. I., She Z., Kraatz H.-B. (2017). Electrochemical studies of tau protein-iron interactions—Potential implications for Alzheimer’s Disease. Electrochim. Acta 236 384–393. 10.1016/j.electacta.2017.03.175 - DOI

LinkOut - more resources